Advanced Filters
noise

Madison, Wisconsin Clinical Trials

A listing of Madison, Wisconsin clinical trials actively recruiting patient volunteers.

Found 341 clinical trials
J Jack Jiang, MD

Aerodynamic Measurements in the Pediatric Population

The goal of this clinical trial is to create a vocal health database of people aged 4-17 with no diagnosed voice pathology. The main question it aims to answer is: what is the best way to assess pediatric voices; and, what are the differences between healthy and dysphonic pediatric voices? …

4 - 17 years of age All Phase N/A
S Shari Barlow

ORCHARDS-AIR Study

The purpose of this observational study is to compare the effectiveness of air surveillance and to better understand the relationship between household transmission and viruses detected in the air. Participants will provide nasal swabs and have an air sample surveillance device installed in their home.

4 years of age All Phase N/A
S Stephanie Wilson

Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis

The goal of this clinical trial is to gain more information about how fibroblast activation protein inhibitor (FAPI) binds to a certain type of cells in fibrotic lung tissue and how this information can be used to better diagnose and track fibrotic lung disease activity. Participants will undergo up to …

18 years of age All Phase 2

Well-being Skills for Reentry

The goal of this clinical trial is to learn if a mindfulness skills training program has mental health benefits for people returning to the community following incarceration. The main questions it aims to answer are: Does mindfulness skills training improve symptoms of anxiety and depression? Do participants find this mindfulness …

18 years of age All Phase N/A

Exercise-priming of CBT for Depression: the CBT+ Trial

This study investigates the effects of intentionally sequencing aerobic exercise immediately prior to cognitive behavioral therapy (CBT) to determine its effects on mechanisms of CBT (i.e., working alliance, behavioral activation). To assess the utility of this treatment augmentation, investigators will conduct a randomized controlled trial involving 100 adults with Major …

18 - 65 years of age All Phase N/A
C Cancer Connect

Evaluating the Communication Between Patients and Providers in Cancer Clinics

This clinical trial seeks to understand patients' experiences with the healthcare team and the quality of communication between patients and doctors in cancer clinics. The main question it aims to answer is: Does TrialTalk™ improve communication between providers and patients? Participants will complete questionnaires before and after their standard of …

18 years of age All Phase N/A

Comparing Outcomes and Complications Following Mastisol Application for Clubfoot Casting

The purpose of this study is to assess if the application of Mastisol, a liquid adhesive, improves outcomes during bilateral clubfoot casting and reduces complications and development of complex clubfoot for the duration of their casting and up to 5 years follow-up.

- 8 years of age All Phase N/A
C Cancer Connect

Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer

This is a multicenter, single-arm, two-stage open-label phase 2 study of the combination of cabozantinib + nivolumab in subjects with advanced castration-resistant prostate cancer (CRPC).

18 years of age Male Phase 2

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer

This is a multicenter, Phase 1b/2 trial. The phase 1b part of the trial aims to determine the RP2D of elacestrant when administered in combination with alpelisib, everolimus, palbociclib, abemaciclib, and ribociclib. The Phase 2 part of the trial will evaluate the efficacy and safety of the various combinations in …

18 years of age All Phase 1/2
E Erin E. Zielinski

Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma

This is a Phase I/II, multicenter, open-label, dose escalation/dose-expansion study to evaluate the tolerability, safety, and the maximum tolerated dose (MTD) of ruxolitinib when given with fixed dose nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma (cHL).

18 years of age All Phase 1/2

Simplify language using AI